Skip to main content

Breadcrumb

  1. Home

Perinatal and Women's Health

Chlamydia Screening in Women (CHL)

  • The percentage of women 16–24 years of age who were identified as sexually active and who had at least one test for chlamydia during the measurement year.

    CBE ID
    0033

Contraceptive Care - Access to LARC

  • Percentage of women aged 15-44 years at risk of unintended pregnancy that is provided a long-acting reversible method of contraception (i.e., implants, intrauterine devices or systems (IUD/IUS)).

    It is an access measure because it is intended to identify very low rates (less than 1-2%) of long-acting reversible methods of contraception (LARC), which may signal barriers to LARC provision.

    CBE ID
    2904

Contraceptive Care - Postpartum

  • Among women ages 15 through 44 who had a live birth, the percentage that is provided:
    1) A most effective (i.e., sterilization, implants, intrauterine devices or systems (IUD/IUS)) or moderately (i.e., injectables, oral pills, patch, or ring) effective method of contraception within 3 and 60 days of delivery.

    2) A long-acting reversible method of contraception (LARC) within 3 and 60 days of delivery.

    CBE ID
    2902

Contraceptive Care – Most & Moderately Effective Methods

  • The percentage of women aged 15-44 years at risk of unintended pregnancy that is provided a most effective (i.e., sterilization, implants, intrauterine devices or systems (IUD/IUS)) or moderately effective (i.e., injectables, oral pills, patch, or ring) method of contraception.

    The measure is an intermediate outcome measure because it represents a decision that is made at the end of a clinical encounter about the type of contraceptive method a woman will use, and because of the strong association between type of contraceptive method used and risk of unintended pregnancy.

    CBE ID
    2903

ePC-02 Cesarean Birth

  • This measure assesses the number of nulliparous women with a term, singleton baby in a vertex position delivered by cesarean birth.  

    CBE ID
    0471e

Incidence of Episiotomy

  • Percentage of vaginal deliveries (excluding those coded with shoulder dystocia) during which an episiotomy is performed.

    CBE ID
    0470

Neonatal Blood Stream Infection Rate (NQI 03)

  • Discharges with healthcare-associated bloodstream infection per 1,000 discharges for newborns and outborns with birth weight of 500 grams or more but less than 1,500 grams; with gestational age between 24 and 30 weeks; or with birth weight of 1,500 grams or more and death, an operating room procedure, mechanical ventilation, or transferring from another hospital within two days of birth. Excludes discharges with a length of stay less than 3 days and discharges with a principal diagnosis of sepsis, or bacteremia, or newborn bacteremia.

    CBE ID
    0478

PC-03 Antenatal Steroids

  • This measure assesses patients at risk of preterm delivery at >=24 and <34 weeks gestation receiving antenatal steroids prior to delivering preterm newborns. This measure is a part of a set of five nationally implemented measures that address perinatal care (PC-01: Elective Delivery, PC-02: Cesarean Birth, PC-04: Health Care-Associated Bloodstream Infections in Newborns, PC-05: Exclusive Breast Milk Feeding; Beginning 1/1/2019 PC-06 Unexpected Complications in Term Newborns will be added).

    CBE ID
    0476

PC-04 Health Care-Associated Bloodstream Infections in Newborns

  • This measure assesses the number of staphylococcal and gram negative septicemias or bacteremias in high-risk newborns. This measure is a part of a set of five nationally implemented measures that address perinatal care (PC-01: Elective Delivery, PC-02: Cesarean Birth, PC-03: Antenatal Steroids, PC-05: Exclusive Breast Milk Feeding; Beginning 1/1/2019 PC-06 Unexpected Complications in Term Newborns will be added).

    CBE ID
    1731